ArticleERJ open research2026
A simple score to identify the sickest normotensive patients with acute pulmonary embolism.
Article in ERJ open research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Oxygen saturation and mortality for acute pulmonary embolism: multinational retrospective cohort study.EClinicalMedicine · 2026Article
Corrections and comments
- Erratum issued
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Emerging evidence suggests that various prognostic factors should be combined to identify normotensive patients with pulmonary embolism (PE) at intermediate-high risk for a short-term complicated course. We proposed and externally validated a pragmatic score to identify those patients. Methods: The SIMpLe risk score contained vital Signs, IMaging testing and Laboratory tests. For the primary outcome of 30-day all-cause mortality and the secondary outcome composed of clinical deterioration or PE-related mortality, three independent cohorts from sites in Europe were used to assess overall score performance, discrimination, calibration and prediction. Results: The participants had a median (interquartile range) age of 72 (59-80) years in the PROTECT derivation cohort, 73 (66-82) years in TELOS and 69 (59-81) years in the Ramón y Cajal external validation cohorts. Women comprised 51-58% of each cohort. The SIMpLe score had areas under the curve of 0.69, 0.78 and 0.71 in the PROTECT, TELOS and Ramón y Cajal cohorts for the primary outcome, respectively. The score had good calibration. Using a threshold of a 15% probability of 30-day all-cause mortality, the risk score created a binary test with a positive predictive value of 23.5% in PROTECT, 26.7% in TELOS and 27.0% in Ramón y Cajal. For the composite secondary outcome, the risk score created a binary test with a positive predictive value of 23.5% in PROTECT, 26.7% in TELOS and 28.6% in Ramón y Cajal. Conclusions: The SIMpLe score can be applied to identify the sickest normotensive patients with acute PE and to support shared decision-making.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.